Developer docs
API playgroundTry for free, no card

Search company profiles

Bevimi

Full company profile

uuid00ypwcc

Namestring
Bevimi
Legal namestring
Bevimi, Inc.
Websiteurl
mybevimi.com
Company typeenum
Private
Founded yearint
2025
Short descriptiontext

Bevimi is a cognitive health company selling Uno Protect, a liquid brain supplement with 10 clinically studied ingredients, direct-to-consumer via subscription at $128 per 12-pack, targeting health-conscious adults seeking memory, focus, and cognitive longevity support.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersGreenwich, United States
HQ citystring
Greenwich
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cognitive health supplements, brain health products, nootropic liquid supplements, dietary supplements, cognitive longevity nutrition
Industry3 codes
PRIMARYCRADAGAM
Healthy Aging & Cognitive Support Supplements
SECONDARYCRADAGAE
Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity)
SECONDARYCRADAGAC
Multivitamins & Daily Packs
NAICS code2 codes
  • Food (Health) Supplement Retailers456191
  • Health and Personal Care Retailers456
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Cognitive Health Supplements
Social media profiles4 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Uno Protect Product Sales
TypeSubscription Recurring
Description

Direct-to-consumer sales of Uno Protect cognitive health supplement at $128 per 12-pack. The product is sold through the company's e-commerce website with subscription options offering a 10% discount and free shipping.

mybevimi.com
2Affiliate Program Revenue
TypeAffiliate Referral
Description

Commission-based revenue sharing with affiliates who promote Bevimi products through referral links and coupon codes. Commissions are earned on approved purchases made through affiliate links within a 30-day cookie window.

mybevimi.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations, Others
Pricing details2 tiers
112-pack of Uno Protect at $128 USD (approximately $10.67 per daily dose)
ModelSubscriptionBilling cadenceMonthly
Notes

Regular price: $128.00 USD per 12-pack. Subscription option offers 10% discount with free shipping. Sold exclusively in packs of 12.

mybevimi.com
2Affiliate commission structure for referral sales
ModelOtherBilling cadencePay-as-you-go
Notes

Affiliates earn commission on every sale through referral links. Customers receive discounts when using affiliate coupon codes.

mybevimi.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Bevimi manufactures and sells Uno Protect, a patent-pending daily liquid brain health supplement that delivers ten clinically studied active ingredients in a single 1.7-ounce shelf-stable serving, replacing approximately 20 capsules. The product is sold direct-to-consumer via the company's Shopify-powered website with subscription options and through an affiliate partner network, targeting adults seeking to support memory, focus, and long-term cognitive health.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Replaces 20 capsules with single 1.7oz liquid dose
+3 more records
Product overview1 text field

Bevimi is a cognitive health innovation company offering a single core product: Uno Protect. Uno Protect is a patent-pending daily liquid supplement designed to support brain health through ten clinically studied ingredients delivered via a proprietary liquid stabilization technology. The product replaces traditional capsule-based supplements by providing the equivalent of 20 capsules in a single 1.7-ounce serving with enhanced bioavailability. Sold exclusively in packs of 12 bottles ($128 USD), the product is currently available through the company's website with broader retail rollout planned for 2026.

Product and service1 record
1Uno Protect
CategoryCognitive Health Supplement
Description

A patent-pending daily liquid brain health supplement delivering ten clinically studied active ingredients in a single 1.7-ounce dose. Formulated to support memory, focus, cognitive longevity, neuro-immune function, and mood by using proprietary liquid stabilization technology to enhance bioavailability of fat-soluble compounds including phospholipid-form omega-3s, brain-targeted magnesium (ATA Mg), high-dose curcumin, and quercetin. Sold exclusively in packs of 12 bottles at $128 USD.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-13
Description

Bevimi partnered with Alamar Biosciences to utilize their next-generation inflammatory biomarker panel alongside established cognitive aging biomarkers (p-tau217, neurofilament light) in the planned IRB-approved randomized clinical study beginning in 2026.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Bevimi collaborates with Stanford University researchers, including Chief Science Officer Dr. Annelise E. Barron who has been on the faculty since 2007. The company leverages Stanford neuroscience research for product development.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Premium supplement and nootropics brand (Alpha Brain is its flagship cognitive product) with strong DTC and Amazon presence. Competes directly in the consumer brain-health supplement category.

TypeDirect peer
Description

Thorne is a science-backed supplement brand selling practitioner-grade and DTC nutrition products, including cognitive and nootropic lines. It is the most direct peer: Bevimi's entire executive team is ex-Thorne and the company is explicitly building a 'Thorne-for-the-brain' brand.

TypeBroad incumbent
Description

Long-established supplement brand with broad cognitive and longevity product portfolio, strong practitioner channel and large customer base. Provides a benchmark for scale in the cognitive supplement category.

TypeEmerging player
Description

Specialty retailer of cognitive supplements and bulk nootropics with strong reputation in the biohacker community. Competes on price and ingredient breadth rather than clinical framing — useful reference for Bevimi's competitive set.

TypeDirect peer
Description

Best-known premium universal nootropic stack with multi-pathway formulation philosophy similar to Uno Protect's design rationale. Competes for the same 'cognitive optimization' consumer and uses similar bioactives (phospholipids, B vitamins, etc.).

TypeDirect peer
Description

Premium supplement brand with sports/professional athlete channel partnerships (including NFL, NBA, US Ski Team) selling cognitive, sleep and recovery products. Strong brand-pricing and practitioner/sports overlap with Bevimi's go-to-market.

7BrainMD
TypeEmerging player
Description

Cognitive and brain-health supplement brand founded by psychiatrist Dr. Daniel Amen, selling through DTC and practitioner channels. Comparable clinical-positioning strategy and similar core customer persona.

TypeEmerging player
Description

DTC nootropics brand offering personalized, customizable supplement formulas targeting cognitive performance. Comparable to Bevimi in target consumer and premium positioning, though with a customization angle Bevimi lacks.

TypeDirect peer
Description

Sells premium nootropic stacks (Qualia Mind/Life) with multi-ingredient, clinically-dosed formulations targeting cognition, mood and longevity. Closest competitor to Uno Protect on positioning — premium, science-forward, full-disclosure brain supplements sold DTC.

10AG1 (Athletic Greens)
TypeBroad incumbent
Description

Premium daily foundational nutrition drink with cognitive and energy benefits — a direct form-factor and price-point comparator for Bevimi's liquid daily-dose approach. Sets the bar for premium subscription DTC supplement economics.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bevimi

Cognitive Health Supplementsmybevimi.com

Bevimi is a cognitive health company selling Uno Protect, a liquid brain supplement with 10 clinically studied ingredients, direct-to-consumer via subscription at $128 per 12-pack, targeting health-conscious adults seeking memory, focus, and cognitive longevity support.

Bevimi firmographics

Firmographics
Name
Bevimi
Legal name
Bevimi, Inc.
Website
https://mybevimi.com
Company type
Private
Founded year
2025
Operating status
Operating
Headcount range
1–10 employees
Short description
Bevimi is a cognitive health company selling Uno Protect, a liquid brain supplement with 10 clinically studied ingredients, direct-to-consumer via subscription at $128 per 12-pack, targeting health-conscious adults seeking memory, focus, and cognitive longevity support.
Ownership category
akta.pro rank

Bevimi industry classification

Industry
Product category
Cognitive Health Supplements
NAICS
Food (Health) Supplement Retailers (456191), Health and Personal Care Retailers (456)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYCRADAGAM
Healthy Aging & Cognitive Support Supplements
SECONDARYCRADAGAE
Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity)
SECONDARYCRADAGAC
Multivitamins & Daily Packs

Keywords

  • Cognitive health supplements
  • Brain health products
  • Nootropic liquid supplements
  • Dietary supplements
  • Cognitive longevity nutrition

Where Bevimi is headquartered

Location

Headquarters

HQ city
Greenwich
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Bevimi business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations, Others

Revenue model

  1. Uno Protect Product Sales: Direct-to-consumer sales of Uno Protect cognitive health supplement at $128 per 12-pack. The product is sold through the company's e-commerce website with subscription options offering a 10% discount and free shipping.
  2. Affiliate Program Revenue: Commission-based revenue sharing with affiliates who promote Bevimi products through referral links and coupon codes. Commissions are earned on approved purchases made through affiliate links within a 30-day cookie window.

Pricing tiers

ModelBillingPrice
SubscriptionMonthly12-pack of Uno Protect at $128 USD (approximately $10.67 per daily dose)
OtherPay-as-you-goAffiliate commission structure for referral sales

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Bevimi product offering

Product offering

Core offering

Bevimi manufactures and sells Uno Protect, a patent-pending daily liquid brain health supplement that delivers ten clinically studied active ingredients in a single 1.7-ounce shelf-stable serving, replacing approximately 20 capsules. The product is sold direct-to-consumer via the company's Shopify-powered website with subscription options and through an affiliate partner network, targeting adults seeking to support memory, focus, and long-term cognitive health.

Product overview

Bevimi is a cognitive health innovation company offering a single core product: Uno Protect. Uno Protect is a patent-pending daily liquid supplement designed to support brain health through ten clinically studied ingredients delivered via a proprietary liquid stabilization technology. The product replaces traditional capsule-based supplements by providing the equivalent of 20 capsules in a single 1.7-ounce serving with enhanced bioavailability. Sold exclusively in packs of 12 bottles ($128 USD), the product is currently available through the company's website with broader retail rollout planned for 2026.

Differentiator

Problem solved

Functional benefit

Products and services

  • Uno Protect A patent-pending daily liquid brain health supplement delivering ten clinically studied active ingredients in a single 1.7-ounce dose. Formulated to support memory, focus, cognitive longevity, neuro-immune function, and mood by using proprietary liquid stabilization technology to enhance bioavailability of fat-soluble compounds including phospholipid-form omega-3s, brain-targeted magnesium (ATA Mg), high-dose curcumin, and quercetin. Sold exclusively in packs of 12 bottles at $128 USD.

Quantifiable outcome

  • Replaces 20 capsules with single 1.7oz liquid dose
  • +3 more outcomes

Companies that use Bevimi

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Bevimi technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Bevimi partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Alamar BiosciencescoreTechnology or Integration · 13 May 2026Bevimi partnered with Alamar Biosciences to utilize their next-generation inflammatory biomarker panel alongside established cognitive aging biomarkers (p-tau217, neurofilament light) in the planned IRB-approved randomized clinical study beginning in 2026.
  • Stanford UniversitycoreStrategic or Co-development PartnerBevimi collaborates with Stanford University researchers, including Chief Science Officer Dr. Annelise E. Barron who has been on the faculty since 2007. The company leverages Stanford neuroscience research for product development.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Bevimi competitors and assessment

Company assessment

Direct peers

  • Onnit: Premium supplement and nootropics brand (Alpha Brain is its flagship cognitive product) with strong DTC and Amazon presence. Competes directly in the consumer brain-health supplement category.
  • Thorne HealthTech: Thorne is a science-backed supplement brand selling practitioner-grade and DTC nutrition products, including cognitive and nootropic lines. It is the most direct peer: Bevimi's entire executive team is ex-Thorne and the company is explicitly building a 'Thorne-for-the-brain' brand.
  • Mind Lab Pro: Best-known premium universal nootropic stack with multi-pathway formulation philosophy similar to Uno Protect's design rationale. Competes for the same 'cognitive optimization' consumer and uses similar bioactives (phospholipids, B vitamins, etc.).
  • Momentous: Premium supplement brand with sports/professional athlete channel partnerships (including NFL, NBA, US Ski Team) selling cognitive, sleep and recovery products. Strong brand-pricing and practitioner/sports overlap with Bevimi's go-to-market.
  • Neurohacker Collective (Qualia): Sells premium nootropic stacks (Qualia Mind/Life) with multi-ingredient, clinically-dosed formulations targeting cognition, mood and longevity. Closest competitor to Uno Protect on positioning — premium, science-forward, full-disclosure brain supplements sold DTC.

Broad incumbents

  • Life Extension: Long-established supplement brand with broad cognitive and longevity product portfolio, strong practitioner channel and large customer base. Provides a benchmark for scale in the cognitive supplement category.
  • AG1 (Athletic Greens): Premium daily foundational nutrition drink with cognitive and energy benefits — a direct form-factor and price-point comparator for Bevimi's liquid daily-dose approach. Sets the bar for premium subscription DTC supplement economics.

Emerging players

  • Nootropics Depot: Specialty retailer of cognitive supplements and bulk nootropics with strong reputation in the biohacker community. Competes on price and ingredient breadth rather than clinical framing — useful reference for Bevimi's competitive set.
  • BrainMD: Cognitive and brain-health supplement brand founded by psychiatrist Dr. Daniel Amen, selling through DTC and practitioner channels. Comparable clinical-positioning strategy and similar core customer persona.
  • Thesis: DTC nootropics brand offering personalized, customizable supplement formulas targeting cognitive performance. Comparable to Bevimi in target consumer and premium positioning, though with a customization angle Bevimi lacks.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Bevimi social profiles

Digital presence

Bevimi compliance and trust

Trust signal

Compliance1 record

Bevimi financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bevimi leadership team

Management profile

Number of profiles

Profiles10 records

Bevimi funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bevimi M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bevimi

What does Bevimi do?

Bevimi manufactures and sells Uno Protect, a patent-pending daily liquid brain health supplement that delivers ten clinically studied active ingredients in a single 1.7-ounce shelf-stable serving, replacing approximately 20 capsules. The product is sold direct-to-consumer via the company's Shopify-powered website with subscription options and through an affiliate partner network, targeting adults seeking to support memory, focus, and long-term cognitive health.

Is Bevimi a public or private company?

Bevimi is a private company. It is classified as venture growth investor backed and is currently operating.

When was Bevimi founded?

Bevimi was founded in 2025. It employs 1 to 10 people.

Where is Bevimi based?

Bevimi is headquartered in Greenwich, United States, in the North America region.

How does Bevimi make money?

Two revenue lines are on record. Uno Protect Product Sales are the primary driver. The others are affiliate Program Revenue.

Who are Bevimi's main competitors?

Direct peers on record are Onnit, Thorne HealthTech, Mind Lab Pro, Momentous and Neurohacker Collective (Qualia). Broad incumbents are Life Extension and AG1 (Athletic Greens). Emerging players are Nootropics Depot, BrainMD and Thesis.

Does Bevimi have an API?

No public API is recorded for Bevimi.

What industry is Bevimi in?

Bevimi's product category is Cognitive Health Supplements. Its primary akta.pro industry code is CRADAGAM, Healthy Aging & Cognitive Support Supplements, with a secondary code of CRADAGAE, Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity). Its NAICS code is 456191 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business & FinancialBevimi Selected For Up To $2 Million In ARPA-H Funding To Study Early Cognitive Change And Alzheimer's-Related BiologyBevimi received up to $2 million in ARPA-H funding for the PRISMM study, a randomized, double-blind, placebo-controlled trial of 150 U.S. adults ages 45–70 with subjective cognitive decline. The 24-week study will collect over 15,000 molecular measurements per participant, including biomarkers like p-tau217, to characterize early cognitive change.Grit Daily NewsBEVIMI Launches Uno Protect, a Patent-Pending Liquid Brain Health Formulation with Ten Clinically Studied ActivesBEVIMI, a brain health and wellness platform company, has launched Uno Protect, a patent-pending daily liquid formulation containing ten clinically studied actives designed to support cognitive performance and brain health in healthy adults. The product uses a licensed liquid stabilization technology to deliver fat-soluble bioactive compounds in a single shelf-stable serving, with a full ingredient and dose disclosure. The company, led by former executives from Thorne HealthTech and the former Chief Scientific Officer of Tempus alongside Stanford University collaborators, will conduct an IRB-approved randomized clinical study using Alamar Biosciences' inflammatory biomarker panel, with results to be published regardless of outcome.PR NewswireBEVIMI Launches Uno Protect, a Patent-Pending Liquid Brain Health Formulation with Ten Clinically Studied ActivesBEVIMI announced the launch of Uno Protect, a patent-pending liquid brain health formulation containing ten clinically studied active ingredients delivered as a 1.7-ounce daily shot. The company plans to conduct a randomized, placebo-controlled clinical study beginning in 2026, utilizing Alamar Biosciences' next-generation inflammatory biomarker panel alongside established cognitive aging biomarkers such as p-tau217 and neurofilament light. The product enters a soft launch phase through the company's website and select partners, with broader retail availability planned throughout 2026.YahooBEVIMI Launches Uno Protect, a Patent-Pending Liquid Brain Health Formulation with Ten Clinically Studied ActivesBEVIMI launched Uno Protect, a liquid dietary supplement formulated to support cognitive health and resilience in healthy adults, with a randomized clinical study beginning in 2026. The product contains ten clinically studied actives and is built on proprietary liquid stabilization technology. The formulation addresses challenges of delivering fat-soluble bioactives in a stable liquid form and is covered by patent-pending claims.CullmantimesBEVIMI Launches Uno Protect, a Patent-Pending Liquid Brain Health Formulation with Ten Clinically Studied ActivesBEVIMI, a brain health and wellness platform company, launched Uno Protect, a patent-pending daily liquid formulation containing ten clinically studied actives designed to support cognitive performance and brain health in healthy adults. The product utilizes a novel liquid stabilization technology to deliver fat-soluble bioactive compounds—including phospholipid-form omega-3s, brain-targeted magnesium, high-dose curcumin, and quercetin—in a single 1.7-ounce shelf-stable serving. BEVIMI will conduct a randomized, placebo-controlled clinical study beginning in 2026 to assess safety and biomarker responses, including p-tau217 and neurofilament light markers, in partnership with Alamar Biosciences.EnlightenbioBEVIMI Launches: A New Bid to Bring Pharma-Grade Rigor to Brain HealthBEVIMI was announced as a new company focused on brain health and cognitive wellness, aiming to bring pharmaceutical rigor to consumer products in this market. Their first product is a nutritional beverage for early-stage Alzheimer's, scheduled for launch in 2026, with plans for clinical trials to validate safety and efficacy. The company leverages AI, diagnostics, and its leadership team's experience to differentiate itself from competitors and redefine standards in cognitive health prevention.PR NewswireFormer Leaders of Thorne HealthTech and Tempus Launch Brain Health and Wellness Company BEVIMI at Inaugural CG Well SummitBEVIMI, a new brain health and wellness company co-founded by former Thorne HealthTech CEO Paul Jacobson and Tempus executive Joel Dudley, was officially launched at the inaugural CG Well Summit. The company is developing science-based nutritional products targeting cognitive longevity and neuroinflammation, with its first product for Alzheimer's risk support scheduled to launch early next year following clinical studies. BEVIMI aims to bring pharmaceutical-style rigor to evidence-informed nutrition through proprietary technology focused on multiple biological pathways.MoomooThorne HealthTech和Tempus前高管在首届CG Well峰会上推出脑健康与保健公司BEVIMIBEVIMI, a new brain health and wellness company co-founded by former Thorne HealthTech CEO Paul Jacobson and Tempus CSO Joel Dudley, announced its launch at the inaugural CG Well Summit convened by Canaccord Genuity Group. The company is developing science-based nutritional products targeting cognitive longevity, with its first product slated for an early next year launch aimed at individuals at high risk of Alzheimer's disease.YahooFormer Leaders of Thorne HealthTech and Tempus Launch Brain Health and Wellness Company BEVIMI at Inaugural CG Well SummitBEVIMI, a new brain health and wellness company co-founded by former leaders of Thorne HealthTech and Tempus, officially launched at the inaugural CG Well Summit organized by Canaccord Genuity Group. The company is developing a science-based nutritional beverage targeting cognitive longevity and Alzheimer's risk, with its first product slated for launch early next year following clinical studies. BEVIMI aims to address neuroinflammation and cognitive performance through a multi-ingredient approach backed by pharmaceutical-style rigor.